Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 14 citing articles:

Trends in COVID-19 Vaccine Development: Vaccine Platform, Developer, and Nationality
Ryo Okuyama
Vaccines (2024) Vol. 12, Iss. 3, pp. 259-259
Open Access | Times Cited: 8
Robust COVID-19 Vaccine Responses Despite Filarial Co-Infection: Insights from a Lymphatic Filariasis Cohort in Ghana
Julia Meyer, Jennifer Nadal, Linda Batsa Debrah, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 312-312
Open Access
Next-Generation Adenoviral Vector-Based Vaccines for Severe Acute Respiratory Syndrome Coronavirus-2
Muralimanohara S. T. Murala, Vivek Gairola, Ekramy E. Sayedahmed, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 406-406
Open Access
National Granted Programs and Public Funds for Biopharmaceutical Startups in Japan
Ryo Okuyama
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 3
Open Access
Investigation of Reasons for the Reluctance to get Vaccinated with COVID-19 in the General Population in the South of Kerman Province (A Cross-sectional Study)
Amin Saeedi, Rasoul Raesi, Salman Daneshi, et al.
The Open Public Health Journal (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Equal Maintenance of Anti-SARS-CoV-2 Antibody Levels Induced by Heterologous and Homologous Regimens of the BNT162b2, ChAdOx1, CoronaVac and Ad26.COV2.S Vaccines: A Longitudinal Study Up to the 4th Dose of Booster
Tatiana A. do Nascimento, PATRÍCIA YURI NOGAMI, Camille Ferreira de Oliveira, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 792-792
Open Access | Times Cited: 1
Side Effects of COVID-19 Vaccines in Iraqi Kurdistan: A Population-Based Study
Ibrahim A Naqid, Ahmed A. Mosa, Lilaz S Hito, et al.
Cureus (2024)
Open Access | Times Cited: 1
Immunization of adults in practice
Eva Pernicová
Medicína pro praxi (2024) Vol. 21, Iss. 4, pp. 200-207
Closed Access
Developer and Partnership Differences in COVID-19 and Other Infections: Insights from DNA Vaccines
Ryo Okuyama
Journal of Market Access & Health Policy (2024) Vol. 12, Iss. 4, pp. 317-325
Open Access
Enhanced Humoral and Cellular Immune Responses Elicited by Adenoviral Delivery of SARS-CoV-2 Receptor-Binding Motif Fused to Human Fc
Yea-Jin Lee, Maheswaran Easwaran, Yong‐Sam Jung, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1247-1247
Open Access
Influence of blood trace elements on immune responses and adverse symptoms subsequent to Sinopharm COVID-19 vaccination
Mitra Abbasifard, Kooros Kazerooni, Gholamhossein Taghipour Khaje Sharifi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Leveraging Corporate Assets and Talent to Attract Investors in Japan: A Country with an Innovation System Centered on Large Companies
Ryo Okuyama
Journal of risk and financial management (2024) Vol. 17, Iss. 12, pp. 539-539
Open Access
Progress in modifying and delivering mRNA therapies for cancer immunotherapy
Karan Goel, Isha Chawla, Garima Garima, et al.
Advances in immunology (2024)
Closed Access
Cancer vaccines: an update on recent achievements and prospects for cancer therapy
Arezki Chekaoui, Mariangela Garofalo, Beata Gad, et al.
Clinical and Experimental Medicine (2024) Vol. 25, Iss. 1
Open Access
Page 1

Scroll to top